![Andreja Moset Zupan, left, and Stacey Schutte clad in labcoats and gloves work at a lab bench in a biomedical engineering lab.](https://www.uc.edu/news/articles/2024/01/n21217707/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1704224916809.jpg)
U.S. News: New insights into fibroids might lead to better treatments
UC researchers reveal ways fibroids respond to strain compared to uterine cells
U.S. News & World Report highlighted the University of Cincinnati's research into new avenues to treat fibroids, a painful condition that affects 8 in 10 women during their lifetimes.
Researchers in UC's College of Medicine and College of Engineering and Applied Science found different signaling pathways being used by the fibroid cells compared to the uterine cells.
“That’s important for identifying therapeutic targets because we want to target the tumor without affecting the surrounding tissue,” said Stacey Schutte, an assistant professor of biomedical engineering in UC’s College of Engineering and Applied Science.
The study was published in the journal F&S Science.
In their study, fibroid cells and uterine cells were grown in the lab on plates with an elastic bottom. Researchers then used a vacuum to pull and stretch the cells, mimicking the uterine environment. They saw differences in the way cells held their shape.
"We found that fibroid cells were more sensitive to strain," said lead author Dr. Rachel Warwar, from the University of Cincinnati's College of Medicine. She said the findings underscore the importance of incorporating mechanical strain, and not just hormones, into the study of fibroid cells.
"The more we are able to mimic the environment of these cells in the uterus, the more we will understand the pathology of these cells and then can work to target anomalous pathways in fibroid cells," Warwar added.
Read the U.S. News & World Report story.
Featured image at top: UC Research Associate Andreja Moset Zupan, left, and Assistant Professor Stacey Schutte study new avenues to treat fibroids in Schutte's biomedical engineering lab. Photo/Andrew Higley/UC Marketing + Brand
UC Research Associate Andreja Moset Zupan, left, and Assistant Professor Stacey Schutte study new avenues to treat fibroids in Schutte's biomedical engineering lab. Photo/Andrew Higley/UC Marketing + Brand
Related Stories
Over 100 Mental Health Champions graduated this spring
April 28, 2021
On April 15, 2021, over 100 faculty and staff across the University of Cincinnati graduated to become official Mental Health Champions, a now Healthy UC initiative. These dedicated colleagues successfully completed three trainings focused on creating connections and community, supporting students and co-workers with resources, and investing in their own personal wellness. Trainings were hosted by fellow colleagues who became facilitators in Question, Persuade, Refer (QPR), Counseling and Psychological Services (CAPS), and the Be Well UC employee wellness program. All Mental Health Champions actively demonstrate their commitment to building the culture of positive well-being at the University.
Grad students earn president's highest honor
April 28, 2021
The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
Faculty Awards 2021: Kenneth Sherman
April 8, 2021
Kenneth E. Sherman, MD, PhD, is Gould Professor of Medicine and Director of the UC Division of Digestive Diseases in the Department of Internal Medicine. He is this year recipient of the University of Cincinnati Distinguished Research Professor Award.
UC student leads effort to clean up campus adjacent Coy Field
April 7, 2021
Karthikeyan Sakthivel, a senior medical sciences undergraduate at the University of Cincinnati, has adopted Coy Field in an attempt to keep the green space clean and ready for use by UC students, area high schoolers and the community. Sakthivel is planning another cleanup event for Coy Field, which is adjacent to the university campus.
Vaccine distribution planned on UC campus
April 2, 2021
COVID-19 vaccine distribution planned for Ohio campuses
Celebrate Cicadapocalypse 2021 at Hoxworth Blood Center
May 24, 2021
Celebrate this year’s cicada invasion (or simply escape the hordes of buzzing, red-eyed locusts) by donating blood at Hoxworth Blood Center.
GIVEHOPE and BSI Engineering Celebrate Ten Years of Driving Research
August 3, 2021
Years after two personal losses from pancreatic cancer, Cincinnati-based nonprofit GIVEHOPE and consulting firm BSI Engineering are celebrating a philanthropic partnership that has funded 13 pilot research projects at the University of Cincinnati Cancer Center.
Finding community and building a future
July 9, 2021
As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”
New York Times: Flint Weighs Scope of Harm to Children Caused by Lead in Water
February 1, 2016
Kim Dietrich, a professor of environmental health at UC's College of Medicine, is quoted in this story on the medical problems that could develop among the thousands of young children exposed to lead-contaminated water in Flint, Mich.
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
February 18, 2016
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.